Osaka, Japan

Hiroshi Hagiya

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 5.4

ph-index = 2

Forward Citations = 24(Granted Patents)


Location History:

  • Tsukuba, JP (2010 - 2014)
  • Osaka, JP (2005 - 2024)

Company Filing History:


Years Active: 2005-2024

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Hiroshi Hagiya: Innovator in Cancer and Infectious Disease Treatment

Introduction

Hiroshi Hagiya is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative treatments for cancer and infectious diseases. With a total of six patents to his name, Hagiya's work is recognized for its potential impact on medical science.

Latest Patents

Hagiya's latest patents include a STING agonistic compound, which is a drug or agent containing a compound that exhibits agonistic activity to STING as an active ingredient. This compound is represented by a specific general formula and can be utilized as an active ingredient in agents aimed at suppressing the progression, recurrence, and treatment of cancer or infectious diseases. The innovative nature of this compound highlights Hagiya's commitment to advancing medical treatments.

Career Highlights

Throughout his career, Hiroshi Hagiya has been associated with Ono Pharmaceutical Co., Ltd., where he has played a crucial role in research and development. His expertise in pharmacology and dedication to innovation have positioned him as a key figure in the pharmaceutical industry.

Collaborations

Hagiya has collaborated with notable colleagues, including Masashi Minami and Ryosuke Hanada. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking advancements in medical treatments.

Conclusion

Hiroshi Hagiya's contributions to the field of pharmaceuticals, particularly through his innovative patents, underscore his importance as an inventor. His work continues to pave the way for new treatments that could significantly improve patient outcomes in the fight against cancer and infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…